Mark Avagliano

2019

In 2019, Mark Avagliano earned a total compensation of $5.5M as Chief Business Officer at G1 Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$142,800
Option Awards$5,100,560
Salary$181,913
Other$53,117
Total$5,478,390

Avagliano received $5.1M in option awards, accounting for 93% of the total pay in 2019.

Avagliano also received $142.8K in non-equity incentive plan, $181.9K in salary and $53.1K in other compensation.

Rankings

In 2019, Mark Avagliano's compensation ranked 1,943rd out of 13,971 executives tracked by ExecPay. In other words, Avagliano earned more than 86.1% of executives.

ClassificationRankingPercentile
All
1,943
out of 13,971
86th
Division
Manufacturing
704
out of 5,701
88th
Major group
Chemicals And Allied Products
215
out of 2,200
90th
Industry group
Drugs
172
out of 1,886
91st
Industry
Pharmaceutical Preparations
128
out of 1,398
91st

Pay ratio

Mark Avagliano's Pay$5,478,390
Median Employee's Pay$213,060
Pay Ratio

26

to 1

In 2019, the annual total compensation of Mark Avagliano was $5,478,390.

The annual total compensation of the median employee at G1 Therapeutics was $213,060.

The ratio of Mark Avagliano's pay to the pay of median employee was therefore 26 to one.

Source: SEC filing on April 24, 2020.

Avagliano's colleagues

We found five more compensation records of executives who worked with Mark Avagliano at G1 Therapeutics in 2019.

2019

Mark Velleca

G1 Therapeutics

Chief Executive Officer

2019

Jennifer Moses

G1 Therapeutics

Chief Financial Officer

2019

Rajesh Malik

G1 Therapeutics

Chief Medical Officer

2019

John Demaree

G1 Therapeutics

Chief Commercial Officer

2019

Barclay Phillips

G1 Therapeutics

Chief Financial Officer

News

In-depth

You may also like